Literature DB >> 12517788

Genetic analysis of three-dimensional shape of mouse lung tumors reveals eight lung tumor shape-determining (Ltsd) loci that are associated with tumor heterogeneity and symmetry.

Nikos Tripodis1, Peter Demant.   

Abstract

Most lung tumor linkage studies focus on identifying loci that confer susceptibility or resistance irrespective of the tumor types developed. However, different mouse strains develop different types of lung tumors. A major obstacle for genetic studies of these differences is the lack of reproducible, quantitative, and uniform assessment of tumor type. We have previously described a new variable (Rratio) that assesses the three-dimensional shape of lung tumors in a quantifiable way and showed that nonspherical tumors are correlated with tumor heterogeneity and with a tendency to asymmetrical growth (N. Tripodis and P. Demant, Exp. Lung Res., 27: 521-531, 2001). In the present study, we use the Rratio variable to search for quantitative trait loci affecting tumor phenotype. We tested the F(2) cross between the susceptible strain O20 and the recombinant congenic strain OcB-9. Both develop mixed alveolar and papillary lung tumors, and the OcB9 tumors are, on average, more elongated than the O20 ones. We mapped eight new lung tumor shape-determining loci (Ltsd1-8) involved in mutual interactions. Two of these loci, Ltsd1 and Ltsd3, seem to play a major role in tumor shape formation. The Ltsd4 locus was confirmed in a second F(2) cross between strain O20 and the recombinant congenic strain OcB-6. Genotype-phenotype associations show that nonspherical tumors are correlated with tumor heterogeneity and nonsymmetrical (focal) development of structures. Most of the new Ltsd loci map in regions where susceptibility to lung cancer (Sluc) loci have been previously mapped, raising the question of whether they are identical or closely linked loci. Based on models of tumor growth indicating that supply of nutrients and the ability to create a capillary network may be shape-determining factors (G. P. Pescarmona et al., Med. Hypoth., 53: 497-503, 1999), we suggest as likely candidates for the Ltsd loci genes involved in angiogenesis, vascularization, and capillary patterning. This is the first set of loci that affects qualitative aspects of lung tumors and may provide biologically and clinically interesting indicators of lung tumor progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517788

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Loci controlling lymphocyte production of interferon c after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility.

Authors:  Marie Lipoldová; Helena Havelková; Jana Badalova; Jarmila Vojtísková; Lei Quan; Magdaléna Krulova; Yahya Sohrabi; Alphons P Stassen; Peter Demant
Journal:  Cancer Immunol Immunother       Date:  2010-02       Impact factor: 6.968

2.  A locus on chromosome 8 controlling tumor regionality-a new type of tumor diversity in the mouse lung.

Authors:  Lei Quan; Alan Hutson; Peter Demant
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

3.  ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.

Authors:  Haiyan Sun; Christopher G England; Reinier Hernandez; Stephen A Graves; Rebecca L Majewski; Anyanee Kamkaew; Dawei Jiang; Todd E Barnhart; Yunan Yang; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-25       Impact factor: 9.236

Review 4.  Common polymorphisms in angiogenesis.

Authors:  Michael S Rogers; Robert J D'Amato
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

5.  Comprehensive analysis of lung cancer pathology images to discover tumor shape and boundary features that predict survival outcome.

Authors:  Shidan Wang; Alyssa Chen; Lin Yang; Ling Cai; Yang Xie; Junya Fujimoto; Adi Gazdar; Guanghua Xiao
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.